A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA) (clinicaltrials.gov) - May 30, 2025 - P2 | N=24 | Completed | Sponsor: Kezar Life Sciences, Inc. | Trial completion date: Aug 2025 ➔ Apr 2025 | Active, not recruiting ➔ Completed
Trial completion • Trial completion date • Autoimmune Hepatitis • Immunology • Inflammation
|